$APRE Messy Cup w HandleUgly chart. Need convincing volume to breakout from handle/pennant. Forthcoming announcement on ATR drug candidate (ATRN-119) may drive price action needed.
APRE trade ideas
$APRE next small cap pop!!!! From a technical standpoint we are looking pretty strong as we closed about the 9-day AND the 26-day moving average with high buying pressure whicks which is interesting
Now from a company perspective standpoint we are most likely to first get approval on, this would be like the most expensive drug I have EVER heard of! In other words MEGA MEGA profit potential for APRE. So basically this would make more money per patient than any other drug in the ENTIRE cancer industry.
MARKET ALPHA OPTIONS WATCHLIST - APRENASDAQ:APRE
Very unusual options activity came in on this one at 4.79 with the assumption the stock would continue higher by August 8th.
Currently the option play is down but that doesn't mean we haven't found support here and may bounce higher catching some off guard. If not the support level is clearly defined.
deep cupgoal is to accumulate 800 to 1.5K shares in this thing until we see some major gap fills. Currently sitting on 150 shares, watching it daily. The Street just left it for dead, liking this $5 handle for accum, no stops, buy weakness, just let the pro shorts in this cover and let the chase begin on the back of promising news. 🤙🏽
Key PT levels based on my work currently: $9.44, $18.67, $30.24 and $53.11
APREOnly way I would want to play this stock is if it broke over the $8.4 resistance area and proved that it could have a gap fill potential (likely would not actually fill this gap but should be able to run a bit more). What I’m not loving about this ticker is the news was ultra fluffy AND there’s a lot of resistance. Of course that doesn’t mean it can’t work, but I’ll personally be waiting for the $8.4 area break first.
APRE MASSIVE MOVE COMING JULY 16 CALL OPTIONSFirst, this stock is just beaten down in no way shape or form should it be at this price. 30% shorted really the only reason. Beat EPS decent ER nothing unordinary for a Bio stock. This is the definition of primed and ready to go. Extremely obvious with the candle build up at the bottom of the pattern. Easily a $5 target. Call options July 16th 7.50 call. Yes it seems weird since it's not a "liquid option" but is traded and will gain IV and price movement which is how you make the real profits. Even buying the stock it clearly has $5-$7 written all over it let alone a MASSIVE gap to fill.
APREAprea Therapeutics Inc (NASDAQ:APRE) The last few days the stock has seen increased volume and price. From a technical standpoint, the stock looks to have bottomed. It broke the falling wedge pattern and could eventually rally up to test its 100-day EMA in the coming days. In addition, MACD, RSI and ADX also indicate positive momentum. To think APRE was trading at $8.4 not long ago. This is worth watching and possibly stepping in for a trade.
APRE **ON HIGH ALERT**All,
This of course has a massive gap. However, it has had a rough prior history however day traders won't see it that way. Once it gains traction upwards this could move fast and not only to $6-$7 but fill that massive gap. I am not suggestions a long hold necessarily, but a hold at this level would not be horrible. Either way based on recent positibve news and TA should be a winner sooner rather than later.
"Aprea Therapeutics: Believes Its Cash and Cash Equivalents as of Dec 31, 2020 Will Be Sufficient to Meet Its Current Projected Operating Requirements Into 2023 "
"Aprea Therapeutics Granted FDA Orphan Drug Designation for Eprenetapopt to Treat Leukemia"
APRE- ANOTHA ONE TO THE MOON- SWING WITH GREAT RISK TO REWARDVery similar to the INVO play i posted last week.
Another very overextended gap down on some bad news caused a panic sell off. These are my favorite setups I think believe the risk to reward ratio are some of the highest on these setups.
I'm looking to get in really at any price around todays close of $7.11. as long as it holds support at around 7, i think this is getting ready for the next leg up which would be to retest and hopefully break the $9.50 mark.
With my price target above 15, this is a YOLO type swing for me where I'm risking quite a bit (stop loss is around $5.00) but the reward is so much greater.
With this in mind I will be scaling back on size for this trade, and give it time to play out.
I'm hoping to hit price target by the summer at the latest, when they announce their q1 results from their clinical trials.
Goodluck Traders! Please let me know your thoughts on this trade below!
APRE Technical Analysis 🧙Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).
$APRE PT 25.50+ Gap UpAprea Therapeutics, Inc. (APRE) is currently trading near its all-time low, and fell earlier this year due towards a failed late-stage cancer therapy study. In the near-term we could see a bounce off the 5.71 support line, before a fill towards 9.20. After hitting this fill, we should then expect a period of consolidation, and finally a last fill towards 25.50+ with expected good news in a 3-4 month time frame.
Note: this is not an investment idea, just my opinion.
Buy APRE Long Term Easy GainsAprea Therapeutics dropped over 70% in December, and now that it shows strong upside, this stock is pure gold. It is riding around 6.67 right now, and I think that it has the potential to reach up to 30$ this year. I will let you know if you should sell. I have already entered here, but you could wait to buy until it drops into the lower half of the Linear Regression Channel for better value. Like and Follow for more ideas like this! Good Luck
**If you want an example of how these biotechs that drop a lot build back up, take a look at UBX**
